By also analyzing the publicly available myeloma GSE6477 microarray dataset, the authors show a significant increase in SphK2 mRNA expression in CD138+ cells from newly diagnosed MM patients as compared to MGUS, while finding no significant difference in SphK1 expression levels. This evidence concerns the gene SDC1 and Miyoshi myopathy.